Although cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible safety risks.
Orgesa Cepo, Senior Clinical Pharmacist
Advertisement
Articles by Orgesa Cepo, Senior Clinical Pharmacist
Advertisement
Latest Updated Articles
Reassessing the Safety and Efficacy of Very Low LDL CholesterolPublished: July 9th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Controversial 340B Rebate Pilot Program Is Moving Forward
2
Striking the Balance: Evidence-Based versus Defensive Medicine
3
Researchers Identify Key Lipid Pathways That Influence Alzheimer’s Progression
4
Symbravo Offers Multi-Mechanistic Option for Patients With Unmet Migraine Needs
5
